Marc Lafoley
M. Sc.
Director
Marc began his career in healthcare more than 25 years ago in pharmaceuticals at an entry level position and quickly rose to commercial leadership positions across several healthcare organizations. Marc’s experience spans multiple commercial areas including sales, analytics, brand management, digital marketing, operations and trade.
Marc has broad experience across numerous therapeutics areas including biologics, pharmaceuticals, medical devices and consumer healthcare. He has worked on several product launches that include the creation of new therapeutic markets, line extensions and late entry products along with successful development and implementation of “loss of exclusivity” strategies for many other products.
From strategy to execution, Marc’s strong analytical and financial skills coupled with his cross-functional experience allow him to support clients in the development, validation and execution of corporate and brand strategies. His experience as a leader and a doer gives him the perspective of advising clients and pull in the resources to get things done. He can help clients transform plans from paper to profit.
Areas of expertise
- Corporate Strategy
- Business Strategy
Recent articles by Marc Lafoley
Pangaea Express: Health Canada's 2023 Distinction Between Advertising and Other Activities
August 14, 2023
Pangaea Express: Quebec Releases Rare Disease Policy
July 15, 2022
Pangaea Express: Quebec Announces Biosimilars Switch Strategy
May 19, 2021
COVID-19 Sparks Transformation of the Pharma Model
May 5, 2021
The Biosimilar: Branded or Generic? Interchangeable or Not?
March 15, 2017